Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves.
This study examines the role of K channel segregation and fiber geometry at transition zones of mammalian nerve terminals in the peripheral nervous system. Mutant mice that are deficient in Kv1.1, a fast Shaker K channel normally localized beneath the myelin sheath, display three types of cooling-induced abnormal hyperexcitability localized to regions before the transition zones of myelinated nerves. The first type is stimulus-evoked nerve backfiring that is absent at birth, peaks at postnatal day 17 (P17), and subsides in adults. The second type is spontaneous activity that has a more delayed onset, peaks at P30, and also disappears in older mice (>P60). TEA greatly amplifies this spontaneous activity with an effective dosage of approximately 0.7 mM, and can induce its reappearance in older mutant mice (>P100). These first two types of hyperexcitability occur only in homozygous mutants that are completely devoid of Kv1.1. The third type occurs in heterozygotes and represents a synergism between a TEA-sensitive channel and Kv1.1. Heterozygotes exposed to TEA display no overt phenotype until a single stimulation is given, which is then followed by an indefinite phase of repetitive discharge. Computer modeling suggests that the excitability of the transition zone near the nerve terminal has at least two major determinants: the preterminal internodal shortening and axonal slow K channels. We suggest that variations in fiber geometry create sites of inherent instability that is normally stabilized by a synergism between myelin-concealed Kv1.1 and a slow, TEA-sensitive K channel.
Department of Physiology, University of Wisconsin School of Medicine, Madison, Wisconsin 53706, USA.
L
L
Zhou
A
A
Messing
S Y
SY
Chiu
D000818:Animals; D003433:Crosses, Genetic; D003964:Diaphragm / Q000294:innervation; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology*; D006579:Heterozygote; D051662:Kv1.1 Potassium Channel; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D018482:Muscle, Skeletal / Q000187:drug effects / Q000294:innervation*; D009413:Nerve Fibers, Myelinated / Q000187:drug effects / Q000502:physiology*; D010791:Phrenic Nerve / Q000502:physiology*; D011188:Potassium / Q000494:pharmacology / Q000502:physiology; D015221:Potassium Channels / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D024642:Potassium Channels, Voltage-Gated; D017729:Presynaptic Terminals / Q000502:physiology; D019789:Tetraethylammonium / Q000494:pharmacology
C496947:Kcna1 protein, mouse; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D051662:Kv1.1 Potassium Channel; D019789:Tetraethylammonium; D011188:Potassium